INTRODUCTION
============

Osteoporotic fractures are important causes of morbidity and place a heavy burden on China's healthcare system [@b1-cln_72p289]. Bone mineral density (BMD), as detected by dual-energy X-ray absorptiometry (DXA), is an accepted diagnostic index for osteoporosis; however, DXA is very expensive and has not been widely applied in primary health care settings in China. A fracture risk assessment tool (FRAX) has been developed by the World Health Organization (WHO) [@b2-cln_72p289]. By considering age, gender, BMD, body mass index (BMI), and other easily obtainable risk factors, the FRAX model can assess a patient's 10-year major osteoporotic fracture probability (MOFP) and 10-year hip osteoporotic fracture probability (HOFP) [@b2-cln_72p289]. FRAX has been successfully used in the UK [@b3-cln_72p289], the USA[@b4-cln_72p289] and Poland [@b5-cln_72p289]. A French study found that the estimated FRAX-based 10-year osteoporotic fracture probability was lower than the actual observed fracture rate in women with low BMD who were over 65 years of age [@b6-cln_72p289]; similar results were also observed in a prospective cohort study performed in Spain [@b7-cln_72p289].

Due to contextual differences between countries, the FRAX model should be calibrated based on each country's own epidemiologic data [@b8-cln_72p289],[@b9-cln_72p289]. The thresholds for therapeutic intervention in postmenopausal women in South-central China [@b10-cln_72p289] are lower than those in the UK [@b3-cln_72p289], Hong Kong [@b11-cln_72p289], and Sri Lanka [@b8-cln_72p289]. Therefore, we applied the FRAX model in a population of middle-aged and elderly healthy (without current serious diseases) community residents to evaluate the fracture probabilities at different sites and assess the applicability of FRAX in Ningbo, China. The prevalence rate of osteoporosis in Ningbo, which is a coastal city in Eastern China with frequent rainstorms and typhoons, observed in those below the age of 60 years is higher than the prevalence rates reported in other regions in China [@b1-cln_72p289],[@b14-cln_72p289], and data suggest that the peak BMD is lower and osteoporosis occurs earlier in residents of Ningbo than in residents of other areas in China [@b12-cln_72p289],[@b13-cln_72p289].

METHODS
=======

Study subjects
--------------

Subjects were consecutively enrolled between July 2013 and June 2015 from the Dongliu Street Community Health Service Center in Ningbo, China. We applied a simple random procedure according to a sequence of computer-generated random numbers to recruit eligible subjects. The inclusion criteria were as follows: healthy subjects aged between 40 and 89 years, healthy local permanent residents who had lived in Ningbo since birth, healthy subjects without a diagnosis of osteoporosis and not taking some certain related drugs, and subjects who could participate in the study independently. All study subjects provided written informed consent, and the study was approved by the Medical Ethics Committee of Jiangdong District. A questionnaire including sociodemographic factors, chronic disease history, menstruation and reproductive history, lifestyle factors, dietary habits and other osteoporosis-related factors was completed by all subjects with the help of trained assistants. A comprehensive physical examination (including BMD, height, weight, electrocardiography and routine blood tests) was also performed.

FRAX calculation
----------------

The 10-year MOFP (hip, clinical spine, humerus or wrist fracture) and the 10-year HOFP were computed using the FRAX model (<http://www.shef.ac.uk/FRAX>) [@b15-cln_72p289]. Fracture risk was calculated based on age, BMI and dichotomized risk factors (comprising prior fragility fractures, parental history of hip fractures, smoking, alcohol consumption, history of steroid use, rheumatoid arthritis and other causes of secondary osteoporosis). In addition, we entered the femoral neck (FN) BMD into the model to enhance its ability to predict fracture risk [@b16-cln_72p289].

BMD evaluation
--------------

BMD was detected at the L1-L4 lumbar spine (LS), FN, and total hip using DXA (Lunar Prodigy, GE, USA). The DXA results were adjusted for age and weight, and Chinese adults aged 20-40 years were used as the reference group. All BMD measurements were performed by a trained licensed technologist. A T score≤-2.5 indicated osteoporosis, a T score\>-2.5 and ≤-1.0 indicated osteopenia, and a T score\>-1.0 indicated normal BMD[@b1-cln_72p289].

Statistical analysis
--------------------

Quantitative data are presented as the mean±standard deviation (SD) and were analyzed using Student's t-tests or one-way ANOVA. Qualitative data are expressed as numbers (percentages) and were analyzed using chi-squared tests. Paired t-tests were used to compare the probabilities of fracture estimated with and without consideration of BMD. Risk stratification and partial correlation analyses were used to analyze the associations between FRAX-based probabilities and BMI or BMD at different sites. P-values\<0.05 were considered statistically significant. All statistical analyses were performed using SPSS version 13.0 (SPSS, Chicago, IL).

RESULTS
=======

Basic characteristics and FRAX-based osteoporotic fracture probability
----------------------------------------------------------------------

A total of 444 (80 males/364 females) subjects were included in this study, and 98% of female subjects were postmenopausal women. Statistically significant differences were found for age, current smoking, current alcohol consumption and secondary osteoporosis between male and female subjects ([Table 1](#t1-cln_72p289){ref-type="table"}). Of the subjects, 175 (39.59%) were diagnosed as osteoporotic, and 208 (47.06%) were diagnosed as osteopenic ([Table 1](#t1-cln_72p289){ref-type="table"}). The rate of osteoporosis was significantly higher among females than males. The Kappa value for the detection of osteoporosis at the LS and FN was 0.314. Statistically significant differences were observed between males and females for the FRAX-based 10-year MOFP and HOFP estimated without consideration of BMD and the 10-year MOFP estimated with consideration of BMD ([Table 1](#t1-cln_72p289){ref-type="table"}). The MOFP and HOFP estimated with and without the consideration of BMD increased with age ([Table 2](#t2-cln_72p289){ref-type="table"}). Significant positive associations were observed between the HOFPs estimated with and without consideration of BMD (r=0.761, P\<0.001) and the MOFPs estimated with and without consideration of BMD (r=0.804, P\<0.001); however, no significant differences were observed subjects with and subjects without BMD measurement.

The association between FRAX-based fracture probability and BMI
---------------------------------------------------------------

Significant negative associations were observed between BMI and FRAX-based fracture probabilities after adjusting for age among the overall subjects, and this difference was especially significant in males and in females when FRAX-based probabilities were calculated without consideration of BMD. While FRAX-based probabilities were calculated with consideration of BMD, a significant association between fracture probability and BMI was only identified in females ([Table 3](#t3-cln_72p289){ref-type="table"})\</underline\>.

FRAX-based fracture probabilities among subjects with different BMD levels
--------------------------------------------------------------------------

Among the three BMD groups (osteoporotic, osteopenic and normal BMD), FRAX-based fracture probabilities were highest in the osteoporosis group and lowest in the normal BMD group. This result remained the same regardless of the diagnostic standards applied. However, in our risk stratification analyses, we found that the estimated FRAX-based fracture probabilities were primarily associated with FN BMD instead of LS BMD. When three stratums were classified based on FN BMD, and then three groups were classified based on LS BMD within each stratum, no statistically significant differences were found among the three groups within each stratum ([Table 4](#t4-cln_72p289){ref-type="table"}). When three stratums were classified based on LS BMD, and then three groups were classified based on FN BMD within each stratum, statistically significant differences were observed among the three groups within each stratum ([Table 4](#t4-cln_72p289){ref-type="table"}). Moreover, significant negative associations were found between the estimated FRAX-based fracture probabilities and FN BMD, even after controlling for LS BMD. Significant negative associations were also observed between the estimated FRAX-based fracture probabilities and LS BMD; however, these significant associations did not remain after controlling for FN BMD ([Table 5](#t5-cln_72p289){ref-type="table"}).

DISCUSSION
==========

In this study, 39.59% of middle-aged and elderly healthy subjects in Ningbo (24.05% males and 42.80% females) were diagnosed as osteoporotic, and these detection rates were higher than the rates previously detected among residents aged over 50 years in China (14.4% males and 20.7% females) [@b1-cln_72p289]. The FRAX-based fracture probabilities (MOFP 4.93%, HOFP 1.64%) identified in this study were higher than the fracture probabilities previously reported in China, such as the probabilities reported in postmenopausal women in Beijing (MOFP of 2% to 4%, HOFP of 0.2% to 1.6%) [@b17-cln_72p289]. Additionally, the fracture probabilities identified in this study were much lower than those previously reported in Taiwanese postmenopausal women (MOFP 13.8%, HOFP 2.2%) [@b18-cln_72p289], postmenopausal women in Hong Kong (MOFP 6.9%, HOFP 2.3%) [@b11-cln_72p289], healthy subjects in the US [@b3-cln_72p289], and women aged ≥50 years in Canada [@b9-cln_72p289].

In this study, the major fracture rate was 2.48% after 1 year of follow-up. Ba et al. found that when the FRAX-based 10-year MOFP was greater than 3% or the HOFP was greater than 1%, the fracture rates at any site were 13.04% among subjects who had received treatment and 31.58% among subjects who had not received any treatment after 2 years of follow-up [@b19-cln_72p289]. Furthermore, consistent with the review conducted by Zhang et al. [@b20-cln_72p289] and the research performed by Min et al. [@b21-cln_72p289], we believe the FRAX model may underestimate the actual fracture probability in China.

Consistent with the study conducted by Fujiwara et al. [@b22-cln_72p289], the FRAX-based fracture probability identified in females was significantly higher than that identified in males in this study, and these results remained stable in different age groups. We found a significant positive association between the FRAX-based osteoporotic fracture probabilities estimated with and without the consideration of BMD, which were both significantly associated with BMD. Similar results were reported in studies conducted in Korea [@b23-cln_72p289] and Beijing [@b17-cln_72p289], and the authors of these studies suggested that the FRAX-based osteoporotic fracture probabilities without and with consideration of BMD could predict the risk of fracture.

Interestingly, we found that the estimated FRAX-based osteoporotic fracture probabilities were strongly associated with FN BMD, especially when BMD was not considered. Risk stratification and partial correlation analyses did not indicate significant associations between the estimated FRAX-based osteoporotic fracture probabilities and LS BMD. Based on these results, it may be inferred that the FRAX tool is more appropriate for the prediction of the osteoporotic fracture of the FN than for osteoporotic fractures of the LS.

Notably, we identified significant negative associations between BMI and FRAX-based fracture probabilities estimated without consideration of BMD. This association was especially significant in subjects with a BMI less than 19, who have an obviously higher fracture risk; however, for subjects with a BMI greater than 19, the fracture risk remained relatively stable. This result was similar to those reported by other studies [@b24-cln_72p289],[@b25-cln_72p289], suggesting that the relationship between BMI and FRAX-based fracture probability is nonlinear and that a low BMI (\<19) might be a risk factor for fracture.

Our study has limitations. The sample size was relatively small; therefore, the extrapolation of our results to the whole population should be performed with caution. The FRAX-based fracture probabilities identified in our study could not be well-verified based on actual fracture rates because the follow-up period of our study was not sufficiently long to obtain sufficient fracture data. Therefore, our results require further confirmation, which we intend to perform in a future study. Nevertheless, our study validates the applicability of the FRAX model in Ningbo, a coastal city in Eastern China with a high prevalence of osteoporosis.

In conclusion, osteoporosis imposes a heavy burden on the population in Ningbo. The Chinese FRAX model could predict osteoporotic fracture risk regardless of whether BMD was considered. This model may be useful to predict osteoporotic fractures of the FN but has a limited ability to predict osteoporotic fractures of the LS. As the Chinese FRAX model may underestimate osteoporotic fracture risk, larger cohort studies that determine actual fracture rates are needed to validate and adjust the Chinese FRAX model. However, the FRAX model may have substantial value for screening and identifying those with a higher risk of osteoporotic fractures in China, especially in many primary medical facilities where BMD cannot be tested due to a lack of DXA equipment.
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###### 

Basic characteristics and FRAX-based 10-year osteoporotic fracture probabilities.

                                                                                                         Total          Males         Females        χ^2^ or t   P
  ------------------------------------------------------------------------------------------------------ -------------- ------------- -------------- ----------- ---------
  Age                                                                                                    63.18±8.93     66.31±8.38    62.49±8.91     3.514       \<0.001
  BMI[1](#tfn1-cln_72p289){ref-type="table-fn"}                                                          23.72±3.15     24.60±3.23    23.53±3.10     2.783       0.006
  BMI\<18.5                                                                                              21 (4.73%)     4 (5.00%)     17 (4.67%)     0.015       0.904
  Prior fracture                                                                                         99 (22.30%)    20 (25.00%)   79 (21.70%)    0.857       0.602
  Parental history of fracture                                                                           46 (10.36%)    8 (10.00%)    38 (10.44%)    0.014       0.907
  Current smoking                                                                                        19 (4.28%)     16 (20.00%)   3 (0.82%)      54.288      \<0.001
  Current alcohol consumption                                                                            46 (10.36%)    29 (36.25%)   17 (4.67%)     70.429      \<0.001
  History of steroid use                                                                                 11 (2.48%)     2 (2.50%)     9 (2.47%)      \<0.001     0.989
  Rheumatoid arthritis                                                                                   21 (4.73%)     1 (1.25%)     20 (5.49%)     1.765       0.184
  Secondary osteoporosis                                                                                 34 (7.66%)     1 (1.25%)     33 (9.07%)     5.666       0.017
  Osteoporosis                                                                                           175 (39.59%)   19 (24.05%)   156 (42.98%)   9.725       0.008
  Osteopenia                                                                                             208 (47.06%)   47 (59.49%)   161 (44.35%)               
  MOFP[2](#tfn2-cln_72p289){ref-type="table-fn"} without BMD[3](#tfn3-cln_72p289){ref-type="table-fn"}   4.93±3.30      3.41±1.77     5.26±3.46      6.859       \<0.001
  HOFP[4](#tfn4-cln_72p289){ref-type="table-fn"} without BMD[3](#tfn3-cln_72p289){ref-type="table-fn"}   1.64±1.90      1.32±1.25     1.71±2.01      2.227       0.027
  MOFP[2](#tfn2-cln_72p289){ref-type="table-fn"} with BMD[3](#tfn3-cln_72p289){ref-type="table-fn"}      4.97±3.53      3.75±2.17     5.24±3.71      4.746       \<0.001
  HOFP[4](#tfn4-cln_72p289){ref-type="table-fn"} with BMD[3](#tfn3-cln_72p289){ref-type="table-fn"}      1.54±2.21      1.53±1.64     1.55±2.32      0.093       0.926

BMI: body mass index;

MOFP: the FRAX-based 10-year major osteoporotic fracture probability;

BMD: bone mineral density;

HOFP: the FRAX-based 10-year hip osteoporotic fracture probability.

###### 

FRAX-based 10-year osteoporotic fracture probabilities among subjects in different age groups.

  Age (years)       N     Without BMD[1](#tfn5-cln_72p289){ref-type="table-fn"}   With BMD                
  ----------------- ----- ------------------------------------------------------- ----------- ----------- -----------
  \<50              22    1.78±0.74                                               0.20±0.18   1.90±0.48   0.28±0.26
  50-59             133   3.37±2.13                                               0.58±0.60   3.59±2.12   0.67±0.79
  60-69             191   5.32±3.20                                               1.61±1.69   5.44±3.80   1.55±2.44
  70-79             79    6.40±3.41                                               3.08±2.18   6.31±3.84   2.89±2.66
  ≥80               19    9.34±3.92                                               4.96±2.02   7.41±3.73   3.28±1.72
  Variance test F         31.439                                                  58.676      16.496      19.555
  P                       \<0.001                                                 \<0.001     \<0.001     \<0.001

BMD: bone mineral density.

###### 

Associations between BMI[1](#tfn7-cln_72p289){ref-type="table-fn"} and FRAX-based 10-year osteoporotic fracture probabilities.

                           Without BMD[2](#tfn8-cln_72p289){ref-type="table-fn"}   With BMD            
  -------------- --------- ------------------------------------------------------- ---------- -------- --------
  All subjects   r         -0.237                                                  -0.339     -0.113   -0.139
  P              \<0.001   \<0.001                                                 0.018      0.004    
  Males          r         -0.238                                                  -0.316     -0.016   -0.042
  P              0.036     0.005                                                   0.887      0.717    
  Females        r         -0.223                                                  -0.338     -0.105   -0.150
  P              \<0.001   \<0.001                                                 0.047      0.005    

Note: The result was derived based on partial correlation analysis after controlling for age;

BMI: body mass index;

BMD: bone mineral density;

MOFP: FRAX-based 10-year major osteoporotic fracture probability;

HOFP: FRAX-based 10-year hip osteoporotic fracture probability.

###### 

FRAX-based 10-year fracture probabilities among groups with different BMD[1](#tfn11-cln_72p289){ref-type="table-fn"} levels in the risk stratification analysis.

  Stratum                                                               Group                                                                 Without BMD   With BMD             
  --------------------------------------------------------------------- --------------------------------------------------------------------- ------------- ---------- --------- ------
  Normal BMD based on FN[^2^](#tfn20-cln_72p289){ref-type="table-fn"}   Normal BMD based on LS[^3^](#tfn21-cln_72p289){ref-type="table-fn"}   3.36          0.68       2.66      0.23
  Osteopenia based on LS                                                4.31                                                                  0.98          3.14       0.25      
  Osteoporosis based on LS                                              3.34                                                                  0.66          2.84       0.3       
  ANOVA F statistic                                                     1.75                                                                  1.326         1.431      0.827     
      P                                                                 0.19                                                                  0.253         0.235      0.366     
  Osteopenia based on FN                                                Normal BMD based on LS                                                4.51          1.48       4.17      1.13
  Osteopenia based on LS                                                4.55                                                                  1.37          4.24       1.05      
  Osteoporosis based on LS                                              4.87                                                                  1.36          4.92       1.24      
  ANOVA F statistic                                                     0.435                                                                 0.248         3.449      0.419     
      P                                                                 0.51                                                                  0.619         0.065      0.518     
  Osteoporosis based on FN                                              Normal BMD based on LS                                                6.07          2.15       7.7       3.03
  Osteopenia based on LS                                                6.66                                                                  3.04          7.13       3.18      
  Osteoporosis based on LS                                              6.7                                                                   2.86          8.46       3.78      
  ANOVA F statistic                                                     0.076                                                                 0.054         1.045      0.671     
      P                                                                 0.783                                                                 0.816         0.309      0.414     
  Normal BMD based on LS                                                Normal BMD based on FN                                                3.35          0.68       2.66      0.23
  Osteopenia based on FN                                                4.51                                                                  1.48          4.17       1.13      
  Osteoporosis based on FN                                              6.07                                                                  2.15          7.7        3.03      
  ANOVA F statistic                                                     9.039                                                                 16.187        40.152     62.962    
      P                                                                 0.003                                                                 \<0.001       \<0.001    \<0.001   
  Osteopenia based on LS                                                Normal BMD based on FN                                                4.31          0.98       3.14      0.25
  Osteopenia based on FN                                                4.54                                                                  1.37          4.24       1.05      
  Osteoporosis based on FN                                              6.66                                                                  3.04          7.13       3.18      
  ANOVA F statistic                                                     8.723                                                                 23.118        38.424     84.782    
      P                                                                 0.004                                                                 \<0.001       \<0.001    \<0.001   
  Osteoporosis based on LS                                              Normal BMD based on FN                                                3.34          0.66       2.84      0.3
  Osteopenia based on FN                                                4.87                                                                  1.36          4.92       1.23      
  Osteoporosis based on FN                                              6.7                                                                   2.86          8.46       3.78      
  ANOVA F statistic                                                     10.297                                                                16.249        26.795     27.027    
      P                                                                 0.002                                                                 \<0.001       \<0.001    \<0.001   

BMD: bone mineral density;

FN: femoral neck;

LS: lumbar spine.

###### 

Associations between FRAX-based 10-year fracture probabilities and BMD[1](#tfn12-cln_72p289){ref-type="table-fn"} at different sites.

                                                           Without BMD   With BMD             
  ---------------------------------------------- --------- ------------- ---------- --------- -------
  FN BMD                                         r         -0.60         -0.60      -0.34     -0.39
  P                                              \<0.001   \<0.001       \<0.001    \<0.001   
  r[4](#tfn15-cln_72p289){ref-type="table-fn"}   -0.52     -0.54         -0.27      -0.34     
  P                                              \<0.001   \<0.001       \<0.001    \<0.001   
  LS BMD                                         r         -0.21         -0.21      -0.34     -0.30
  P                                              \<0.001   \<0.001       \<0.001    \<0.001   
  r[5](#tfn16-cln_72p289){ref-type="table-fn"}   -0.02     0.02          -0.01      0.05      
  P                                              0.615     0.663         0.897      0.265     

BMD: bone mineral density;

MOFP: FRAX-based 10-year major osteoporotic fracture probability;

HOFP: FRAX-based 10-year hip osteoporotic fracture probability;

the relative coefficient derived based on a partial correlation analysis controlling for LS BMD;

the relative coefficient derived based on a partial correlation analysis controlling for FN BMD.
